Stock Events

Stock Events

Atea Pharmaceuticals (AVIR) Q1 2025 Earnings

6MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.75

-0.6

-0.44

-0.29

Details

Expected EPS

-0.288729

Actual EPS

-0.4

Surprise EPS

-0.11

Surprise Percent

+38.54%

Description

Atea Pharmaceuticals (AVIR) has reported earnings of -0.4 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.